Detecting impaired glucose tolerance or type 2 diabetes mellitus by means of an oral glucose tolerance test in HIV-infected patients
Autor: | PierMarco Piatti, Alba Bigoloni, Silvia Nozza, F Visco, Nicola Gianotti, Stefania Salpietro, Concetta Vinci, Laura Galli, Beatrice Barda, A Castagna, Giulia Gallotta, Adriano Lazzarin |
---|---|
Rok vydání: | 2010 |
Předmět: |
Hepatitis B virus
medicine.medical_specialty endocrine system diseases business.industry Health Policy nutritional and metabolic diseases Type 2 Diabetes Mellitus medicine.disease medicine.disease_cause Gastroenterology Impaired glucose tolerance Infectious Diseases Insulin resistance Endocrinology Interquartile range Internal medicine Diabetes mellitus Coinfection Homeostatic model assessment Medicine Pharmacology (medical) business |
Zdroj: | HIV Medicine. 12:109-117 |
ISSN: | 1464-2662 |
DOI: | 10.1111/j.1468-1293.2010.00860.x |
Popis: | Objective As a proactive diagnosis of diabetes mellitus (DM) may prevent the onset of severe complications, we used an oral glucose tolerance test (OGTT) to check for impaired glucose tolerance (IGT) and DM in patients with long-standing HIV infection and long durations of exposure to antiretroviral drugs with normal fasting plasma glucose (FPG) levels. Methods This was a cross-sectional, single-centre study. The homeostatic model assessment for insulin resistance (HOMA-IR) and 2-h post-load glucose levels were used to evaluate patients with known HIV-1 infection since before 1988 and no previous diagnosis of DM for whom data on hepatitis C virus (HCV) and hepatitis B virus (HBV) infection were available. Results Eighty-four Caucasian patients [67 (80%) male; median age 45.7 years; range 43.8–49.1 years] were able to be evaluated; 65 (77%) were coinfected with HCV, and seven (8%) were coinfected with HBV. Median (interquartile range [IQR]) exposure to antiretrovirals was 12.8 (10.4–16.5) years. Fifteen patients (18%) had a previous AIDS-defining event, 64 (76%) had HIV RNA |
Databáze: | OpenAIRE |
Externí odkaz: |